Dr. Hwang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2301 Erwin Rd
Durham, NC 27710Phone+1 919-684-6849- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1992 - 1996
- Kaiser Permanente Southern California (Los Angeles)Internship, Surgery, 1991 - 1992
- David Geffen School of Medicine at UCLAClass of 1991
Certifications & Licensure
- CA State Medical License 1993 - Present
- NC State Medical License 2011 - 2024
- NY State Medical License 1993 - 1998
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ Start of enrollment: 2002 Feb 19
- Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast Start of enrollment: 2017 May 31
- Examining Bioactivity of PVSRIPO in Invasive Breast Cancer Start of enrollment: 2019 Jun 30
Roles: Contact
Publications & Presentations
PubMed
- Immune Phenotype and Postoperative Complications After Elective Surgery.Dimitrios Moris, Richard Barfield, Cliburn Chan, Scott Chasse, Linda Stempora, Jichun Xie, Jennifer K Plichta, Julie Thacker, David H Harpole, Todd Purves, Sandhya Lag...> ;Annals of Surgery. 2023 Dec 1
- How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ.Sydney M Record, Eun-Sil Shelley Hwang, Akiko Chiba> ;Surgical Oncology Clinics of North America. 2023 Oct 1
- 9 citationsRisk factors for persistent pain after breast cancer surgery: a multicentre prospective cohort study.H S Tan, J K Plichta, A Kong, C W Tan, S Hwang, R Sultana, M C Wright, A T H Sia, B L Sng, A S Habib> ;Anaesthesia. 2023 Apr 1
- Join now to see all
Journal Articles
- Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening TrialsShelley Hwang, MD, American Journal of Epidemiology
- Association of Low Nodal Positivity Rate Among Patients with ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Che...Henry M Kuerer, Judy C Boughey, Alison U Barron, E Shelley Hwang, JAMA
- The Association of Extent of Axillary Surgery and Survival in Women with N2–3 Invasive Breast CancerJennifer K Plichta, Oluwadamilola M Fayanju, Rachel C Blitzblau, Rachel A Greenup, Laura H Rosenberger, E Shelley Hwang, Cecilia T Ong, Annals of Surgical Oncology
- Join now to see all
Press Mentions
- New Gene Classifier Identifies Risk of Breast Pre-Cancer Progression, Duke and Stanford Researchers ReportNovember 21st, 2022
- Mission: Interception — Creating Better Ways to Stop Cancer in Its TracksAugust 31st, 2022
- Shelley Hwang, MD, on Helping Patients Make DCIS Management DecisionsMarch 8th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: